Long-term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithms
- PMID: 33354842
- DOI: 10.1111/bdi.13040
Long-term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithms
Abstract
Objectives: This systematic review aimed at providing a critical, comprehensive synthesis of international guidelines' recommendations on the long-term treatment of bipolar disorder type I (BD-I).
Methods: MEDLINE/PubMed and EMBASE databases were searched from inception to January 15th, 2019 following PRISMA and PICAR rules. International guidelines providing recommendations for the long-term treatment of BD-I were included. A methodological quality assessment was conducted with the Appraisal of Guidelines for Research and Evaluation-AGREE II.
Results: The final selection yielded five international guidelines, with overall good quality. The evaluation of applicability was the weakest aspect across the guidelines. Differences in their updating strategies and the rating of the evidence, particularly for meta-analyses, randomized clinical trials (RCTs) and observational studies, could be responsible of some level of heterogeneity among recommendations. Nonetheless, the guidelines recommended lithium as the 'gold standard' in the long-term treatment of BD-I. Quetiapine was another possible first-line option as well as aripiprazole (for the prevention of mania). Long-term treatment should contemplate monotherapy, at least initially. Clinicians should check regularly for efficacy and side effects and if necessary, switch to first-line alternatives (i.e. Valproate), combine first-line compounds with different mechanisms of action or switch to second-line options or combinations.
Conclusions: The possibility to monitor improvements in long-term outcomes, namely relapse prevention and inter-episode subthreshold depressive symptoms, based on the application of their recommendations is an unmet need of clinical guidelines. In terms of evidence of clinical guidelines, there is a need for more efficacious treatment strategies for the prevention of bipolar depression.
Keywords: bipolar disorder type I; clinical guidelines; long-term treatment; maintenance; practice algorithms.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Vieta E, Berk M, Schulze TG, et al. Bipolar disorders. Nat Rev Dis Prim. 2018;4:18008. https://doi.org/10.1038/nrdp.2018.8.
-
- Carvalho A, Firth J, Vieta E. Bipolar disorder. N Engl J Med. 2020;383(1):58-66. https://doi.org/10.1056/NEJMRA1906193.
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th Edn). Arlington, VA: American Psychiatric Association; 2013.
-
- Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet. 2016;387(10027):1561-1572. https://doi.org/10.1016/S0140-6736(15)00241-X.
-
- Samalin L, Murru A, Vieta E. Management of inter-episodic periods in patients with bipolar disorder. Expert Rev Neurother. 2016;16(6):659-670. https://doi.org/10.1080/14737175.2016.1176530.
Publication types
MeSH terms
Substances
Grants and funding
- National Institute for Health Research (NIHR) Biomedical Research Centre at South London
- 754550/European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie
- PI18/00805/Ministerio de Ciencia e Innovación
- PI18/01001/Ministerio de Ciencia e Innovación
- PI19/00672/Ministerio de Ciencia e Innovación
- Fondo Europeo de Desarrollo Regional (FEDER)
- LCF/PR/GN18/50310006/La Caixa" Foundation (ID 100010434)
- 2017_SGR_1365/Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement
- Maudsley NHS Foundation Trust and King's College London
- JR18/0002/Instituto de Salud Carlos III
- CIBERSAM (Centro de Investigación Biomédica en Red de Salud Mental)
- CERCA Programme
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
